Antitumor studies. Part 1: design, synthesis, antitumor activity, and AutoDock study of 2-deoxo-2-phenyl-5-deazaflavins and 2-deoxo-2-phenylflavin-5-oxides as a new class of antitumor agents. Academic Article uri icon

abstract

  • Novel 2-deoxo-2-phenyl-5-deazaflavins and 2-deoxo-2-phenylflavin-5-oxides were prepared as a new class of antitumor agents and showed significant antitumor activities against NCI-H 460, HCT 116, A 431, CCRF-HSB-2, andKB cell lines. In vivo investigation, 2-deoxo-10-methyl-2-phenyl-5-deazaflavin exhibited the effective antitumor activity against A 431 human adenocarcinoma cells transplanted subcutaneously into nude mouse. Furthermore, AutoDock study has been done by binding of the flavin analogs into PTK pp60(c-src), where a good correlation between their IC(50) and AutoDock binding free energy was exhibited. In particular, 2-deoxo-2-phenylflavin-5-oxides exhibited the highest potential binding affinity within the binding pocket of PTK.

published proceedings

  • Bioorg Med Chem

author list (cited authors)

  • Ali, H. I., Tomita, K., Akaho, E., Kambara, H., Miura, S., Hayakawa, H., ... Nagamatsu, T.

citation count

  • 47

complete list of authors

  • Ali, Hamed I||Tomita, Keiichiro||Akaho, Eiichi||Kambara, Hiroto||Miura, Shinji||Hayakawa, Hiroyuki||Ashida, Noriyuki||Kawashima, Yutaka||Yamagishi, Takehiro||Ikeya, Hisao||Yoneda, Fumio||Nagamatsu, Tomohisa

publication date

  • January 2007